Hetero Labs, Ltd. - Unit III recalls

Hetero Labs, Ltd. - Unit III has 5 recalls on record with the FDA and USDA, the earliest in 2017 and the latest reported on 3 Oct 2018.

Total recalls5since 2017

Last 12 months0reported

Class I00% of total

Ongoing0latest 3 Oct 2018

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 3 60%Class III 2 40%

Why hetero labs, ltd. - unit iii is recalled

Product types

Cholesterol Medication240%
Seizure Medication120%

Brands

By year

2018480%
2017120%

All hetero labs, ltd. - unit iii recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
3 Oct 2018Drug	CLASS III	Fenofibrate Tablets, USP 145 mg recalled by Hetero Labs, Ltd. - Unit IIIFenofibrate	Hetero Labs, Ltd. - Unit III	Other	IN, LA
8 Aug 2018Drug	CLASS II	Indomethacin Capsules, USP, 50 mg recalledIndomethacin	Hetero Labs, Ltd. - Unit III	Other	Nationwide
14 Feb 2018Drug	CLASS II	Aripiprazole Tablets, USP, 10 mg recalledAripiprazole	Hetero Labs, Ltd. - Unit III	Manufacturing (CGMP) Deviations	NJ
24 Jan 2018Drug	CLASS III	Simvastatin Tablets, USP, 40 mg recalled by Hetero Labs, Ltd. - Unit IIISimvastatin	Hetero Labs, Ltd. - Unit III	Other	Nationwide
6 Dec 2017Drug	CLASS II	Levetiracetam Oral Solution, USP, 100 mg/mL recalledLevetiracetam	Hetero Labs, Ltd. - Unit III	Packaging Defects	NJ

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.